摘要:
Mammalian proteins and muteins thereof, designated interleukin-4s (IL-4s), are provided which exhibit both B cell growth factor activity and T cell growth factor activity. Compounds of the invention include native human and murine IL-4s, muteins thereof, and nucleic acids which are effectively homologous to disclosed cDNAs, and/or which are capable of coding for mammalian IL-4s and their muteins.
摘要:
Antibodies to mammalian Interleukin-4 and muteins are provided, especially to native human IL-4s, as well as peptides useful as antigens in their production. Nucleic acids are disclosed which are capable of coding for the mammalian IL-4s and their muteins.
摘要:
Antibodies to mammalian Interleukin-4 and muteins are provided, especially to native human IL-4s, as well as peptides useful as antigens in their production. Nucleic acids are disclosed which are capable of coding for the mammalian IL-4s and their muteins.
摘要:
Les anticorps monoclonaux de la présente invention sont spécifiques contre l'interleukine-4 humaine. Des kits et des procédés sont également décrits pour détecter, mesurer et immunopurifier l'interleukine-4 humaine, et pour bloquer l'activité biologique de l'interleukine-4 humaine.
摘要:
De nouvelles protéines interleucine-3 humaines contiennent une substitution non traditionnelle d'acides aminés (Ser --> Pro en position 7) par rapport à des séquences antérieurement décrites d'IL-3 humaine. Des procédés de synthèse de protéines mutantes à conformation et antigénicité neutres sont également décrits. Cette protéine IL-3 humaine favorise la croissance et le développement d'un vaste spectre de lignées hématopoïétiques et peut être utile pour traiter des états caractérisés par une régénération réduite de cellules sanguines et/ou des populations cellulaires, tels que l'hypoplasie de la moelle, des infections chroniques et des thérapies utilisant des transplants de moelle osseuse. La séquence de l'IL-3 décrite est illustrée dans la Figure (I).
摘要:
An immunogenic human interleukin-3 (IL-3) peptide is provided from which monoclonal peptide antibodies can be produced. The peptide of the invention corresponds to an interior subsequence of the IL-3 protein. The invention also includes conjugates of the immunogenic peptide and carriers, and monoclonal antibodies specific for the immunogenic peptide.
摘要:
A polypeptide designated H400 and its encoding nucleic acid are provided as markers specific for activated human T cells. Activated T cells are detected immunochemically by monoclonal antibodies specific for H400 or for its immunogenic peptide fragments. Activated T cells are also detected by nucleic acid probes directed to messenger RNA encoding the H400 protein.
摘要:
Human granulocyte-macrophage colony stimulating factor (GM-CSF) polypeptides are provided, as well as methods for synthesizing conformationally and antigenically neutral muteins. The disclosed GM-CSFs promote growth and development of various hematopoietic lineages, and may be useful in treating conditions involving depressed blood cell populations and/or depressed blood cell regeneration, such as myeloid hypoplasia, chronic infections, and hematopoiesis after bone marrow transplantation. The invention also includes a novel mammalian expression vector.
摘要:
Monoclonal antibodies are provided which are specific for human interleukin-4. Kits and methods are also provided for detecting, measuring and immunopurifying human interleukin-4, and for blocking the biological activity of human interleukin-4.